Literature DB >> 10496357

Colorectal cancer after a negative Haemoccult II test and programme sensitivity after a first round of screening: the experience of the Department of Calvados (France).

V Bouvier1, G Launoy, C Herbert, H Lefevre, J Maurel, M Gignoux.   

Abstract

Colorectal cancers emerging after a negative Haemoccult II are described in the context of a first round of mass screening in the Department of Calvados (France), from April 1991 to the end of December 1994. People with a cancer occurring after a negative test until 31 December 1995 were identified by a local cancer registry. Incidence was calculated and the programme sensitivity was estimated. The incidence of cancer emerging after a negative test was 57.7 per 100000, i.e. half of the calculated incidence in the reference group (141.6 per 100000). These cancers did not differ from those of either the non-responder or reference groups, in particular for the stage of extension. The programme sensitivity was globally higher than that estimated in European trials: 77.2, 66.3 and 55.9%, 1, 2 and 3 years after the test respectively. Programme sensitivity was higher for distal colon cancer 1 year after the test, which is probably due to the relatively slow growth of this subsite.

Entities:  

Mesh:

Year:  1999        PMID: 10496357      PMCID: PMC2362867          DOI: 10.1038/sj.bjc.6990692

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  12 in total

1.  [Mass screening for colorectal cancer in France. Experience in 165,000 people in the department of Calvados].

Authors:  G Launoy; C Herbert; J P Vallée; N Desoubeaux; J M Réaud; V Ollivier; V Bouvier; A Flachs; D Arsène; A Valla; M Gignoux
Journal:  Gastroenterol Clin Biol       Date:  1996

2.  Hemoccult screening in detecting colorectal neoplasm: sensitivity, specificity, and predictive value. Long-term follow-up in a large group practice setting.

Authors:  J E Allison; R Feldman; I S Tekawa
Journal:  Ann Intern Med       Date:  1990-03-01       Impact factor: 25.391

3.  [Digestive cancers in France. Geographic distribution and estimation of national incidence].

Authors:  J Faivre; P Grosclaude; G Launoy; P Arveux; N Raverdy; F Menegoz; P Pienkowski; P Schaffer; J P Daures; F De Vathaire
Journal:  Gastroenterol Clin Biol       Date:  1997

4.  Colorectal cancer mass-screening: estimation of faecal occult blood test sensitivity, taking into account cancer mean sojourn time.

Authors:  G Launoy; T C Smith; S W Duffy; V Bouvier
Journal:  Int J Cancer       Date:  1997-10-09       Impact factor: 7.396

5.  Randomised controlled trial of faecal-occult-blood screening for colorectal cancer.

Authors:  J D Hardcastle; J O Chamberlain; M H Robinson; S M Moss; S S Amar; T W Balfour; P D James; C M Mangham
Journal:  Lancet       Date:  1996-11-30       Impact factor: 79.321

6.  Randomised study of screening for colorectal cancer with faecal-occult-blood test.

Authors:  O Kronborg; C Fenger; J Olsen; O D Jørgensen; O Søndergaard
Journal:  Lancet       Date:  1996-11-30       Impact factor: 79.321

7.  Initial mass screening for colorectal cancer with fecal occult blood test. A prospective randomized study at Funen in Denmark.

Authors:  O Kronborg; C Fenger; O Søndergaard; K M Pedersen; J Olsen
Journal:  Scand J Gastroenterol       Date:  1987-08       Impact factor: 2.423

8.  Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study.

Authors:  J S Mandel; J H Bond; T R Church; D C Snover; G M Bradley; L M Schuman; F Ederer
Journal:  N Engl J Med       Date:  1993-05-13       Impact factor: 91.245

9.  Repeated screening for colorectal cancer with fecal occult blood test. A prospective randomized study at Funen, Denmark.

Authors:  O Kronborg; C Fenger; J Olsen; K Bech; O Søndergaard
Journal:  Scand J Gastroenterol       Date:  1989-06       Impact factor: 2.423

10.  Haemoccult test properties according to type and number of positive slides in mass screening for colorectal cancer.

Authors:  G Launoy; C Herbert; J M Reaud; Y Thezee; J Tichet; J Maurel; V Ollivier; L Pegulu; E Caces; A Valla
Journal:  Br J Cancer       Date:  1995-10       Impact factor: 7.640

View more
  1 in total

Review 1.  Guaiac-based faecal occult blood tests versus faecal immunochemical tests for colorectal cancer screening in average-risk individuals.

Authors:  Esmée J Grobbee; Pieter Ha Wisse; Eline H Schreuders; Aafke van Roon; Leonie van Dam; Ann G Zauber; Iris Lansdorp-Vogelaar; Wichor Bramer; Sarah Berhane; Jonathan J Deeks; Ewout W Steyerberg; Monique E van Leerdam; Manon Cw Spaander; Ernst J Kuipers
Journal:  Cochrane Database Syst Rev       Date:  2022-06-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.